Rare Presentation of Unicentric Castleman's Disease in the Parotid Gland

2012 ◽  
Vol 70 (9) ◽  
pp. 2114-2117 ◽  
Author(s):  
Brynne Reece ◽  
Robert Ord ◽  
John Papadimitriou
2014 ◽  
Vol 107 (8) ◽  
pp. 623-629
Author(s):  
Shinji Mikami ◽  
Daisuke Osaki ◽  
Hideyuki Okamoto ◽  
Toshiaki Yamanaka ◽  
Hiroshi Hosoi

2015 ◽  
Vol 141 (0) ◽  
pp. 90-91
Author(s):  
Shinji Mikami ◽  
Daisuke Osaki ◽  
Hideyuki Okamoto ◽  
Toshiaki Yamanaka ◽  
Hiroshi Hosoi

2009 ◽  
Vol 54 (4) ◽  
pp. 59-59
Author(s):  
Yong Sang Lee ◽  
Soon Won Hong ◽  
Seung Chul Lee ◽  
Kee-Hyun Nam ◽  
Woong Youn Chung ◽  
...  

2018 ◽  
Vol 38 (1) ◽  
pp. 88-91
Author(s):  
Sümeyye EKMEKÇİ ◽  
Gülen GÜL ◽  
Ülkü KÜÇÜK ◽  
Dudu SOLAKOĞLU KAHRAMAN ◽  
Ebru ÇAKIR ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Ruchi Goel ◽  
Akash Raut ◽  
Ayushi Agarwal ◽  
Shweta Raghav ◽  
Sumit Kumar ◽  
...  

Castleman’s disease (CD) is an uncommon group of atypical lymphoproliferative disorders. Extranodal involvement such as the orbit is extremely rare. We aim to report a case of a 62-year-old male who presented with left painless proptosis for the past three years. Examination revealed a firm, lobulated mass in the left superotemporal orbit, displacing the globe inferomedially. A well-defined extraconal orbital lesion encasing the left lateral rectus muscle with intraconal extension was seen on Magnetic Resonance Imaging (MRI) that led to the provisional diagnosis of left solitary encapsulated venous malformation. Excision of the mass via lateral orbitotomy was performed. However, on histopathology, the features were consistent with a mixed-cell variant of Castleman’s disease. A detailed systemic workup was unremarkable. Proptosis resolved after surgery and no recurrence was noted in the three-year follow-up. To the best of our knowledge, this is the first case report of a mixed-cell variant of unicentric orbital CD without any systemic features. This case highlights the importance of including CD in the differential diagnosis of well-defined orbital lesions so as to enable its early detection and timely management.


2017 ◽  
Vol 12 (1) ◽  
pp. 103-104
Author(s):  
Jiun-Sheng Lin ◽  
Chien-Cheng Chen ◽  
Chung-Ji Liu

2011 ◽  
Vol 2011 ◽  
pp. 1-4
Author(s):  
D. Y. Talukder ◽  
S. N. Delpachitra

Introduction. We report a rare presentation of Castleman's disease in a hepatitis C-positive patient and present a short review of treatments described in other similar case reports and studies.Case Presentation. A 46-year-old male with untreated hepatitis C and a 16-year history of intravenous drug use presented with pleuritic chest pain and bony pain in the knee, hip, and lower back, on a background of unexplained weight loss of 40 kilograms, fevers, night sweats, and repeated infections over the last two years. Examination discovered tender hepatomegaly, a warm right knee effusion, and painless lymphadenopathy. The patient was reactive to Epstein Barr virus and cytomegalovirus; however, HIV and HHV-8 viral testing was negative. Osteomyelitis of vertebrae T8–T11 and septic arthritis of the knee were found on investigation. A lymph node biopsy revealed histology suggestive of plasmacytic Castleman's disease. The patient is to commence rituximab treatment.Conclusion. Castleman's disease continues to present in novel ways, which may lead to difficulties in clinicopathologic diagnosis. A growing body of evidence suggests larger studies are required to determine the best treatment for multicentric Castleman's disease, particularly in patients with a concomitant disease, including hepatitis C.


Sign in / Sign up

Export Citation Format

Share Document